Oric Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +55.7% | +101.3% | +217.8% | -0.1% | -16.2% | +1.7% | +7.6% | +49.9% | |
| – | +64.3% | +105.8% | +229.7% | -18.9% | -12.5% | +1.0% | +23.4% | +10.0% | |
| – | +65.1% | +109.1% | -12.0% | +188.1% | -70.4% | -65.0% | +154.0% | -23.1% | |
| – | +65.1% | +109.1% | +229.3% | -19.3% | -13.0% | +0.9% | +22.9% | +10.0% | |
| – | -13.4% | -10.9% | -11.6% | +21.8% | +34.8% | – | – | – | |
| – | +2,485.7% | -94.5% | +50.7% | +178.3% | +9.1% | +9.2% | +1.4% | -14.1% | |
| – | -0.5% | +106.2% | +68.1% | +68.3% | +1.6% | +32.9% | +21.4% | -17.8% | |
| – | – | – | +10.3% | +252.7% | +38.1% | +3.5% | +15.7% | +4.6% | |
| – | -52.6% | -65.9% | +398.0% | +149.1% | -30.0% | -28.5% | +64.0% | +147.0% | |
| – | -350.4% | – | +229.4% | -5.8% | -18.5% | +0.8% | +8.5% | +58.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | +22.9% | +1,624.4% | -26.6% | +73.0% | +4.5% | +29.7% | +35.5% | +25.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.